Close Menu

Synthetic Ethics

Amy Gutmann tells The Scientist that the US presidential commission on bioethics looked for the "Aristotelian mean" between a no-holds-barred approach to synthetic biology and one that prevents the field from moving forward until all risk is removed. "We're likely to recommend that new organisms when they're created should be marked or branded in some manner to be able to monitor development in synthetic biology," Gutmann says, adding that there are multiple ways of doing so.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.